Stock Earnings

Question 1

Bioatla Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Bioatla Inc 的总资产为 $52，净loss为 $-69

Question 2

BCAB 的关键财务比率是什么？

Accepted Answer

Bioatla Inc 的流动比率是 1.36，净利 margin 为 -627.27，每股销售为 $0.22。

Question 3

Bioatla Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Bioatla Inc largest revenue segment is Antibody-based Products, at a revenue of 11,000,000 in the most earnings release.For geography, United States is the primary market for Bioatla Inc, at a revenue of 11,000,000.

Question 4

Bioatla Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Bioatla Inc 的净loss为 $-69

Question 5

Bioatla Inc 有负债吗？

Accepted Answer

yes，Bioatla Inc 的负债为 38

Question 6

Bioatla Inc 的流通股有多少？

Accepted Answer

Bioatla Inc 的总流通股为 58.09

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	--	11	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	--	21	25	28	38	10
Research & Development	--	63	103	79	58	19
Operating Expenses	--	84	129	108	96	30
Other Non Operating Income (Expenses)	--	0	0	0	0	0
Pretax Income	--	-69	-123	-106	-95	-35
Income Tax Expense	--	0	--	--	--	--
Net Income	--	-69	-123	-106	-95	-35
Net Income Growth	--	-44%	16%	12%	171%	25%
Shares Outstanding (Diluted)	--	48.57	47.77	38.93	34.56	32.09
Shares Change (YoY)	--	2%	23%	13%	8%	0%
EPS (Diluted)	--	-1.43	-2.58	-2.74	-2.76	-1.12
EPS Growth	--	-44%	-6%	-1%	146%	24%
Free Cash Flow	-52	-71	-104	-90	-63	-36
Free Cash Flow Per Share	--	-1.46	-2.17	-2.31	-1.82	-1.12
Gross Margin	--	--	--	--	--	--
Operating Margin	--	-663.63%	0%	0%	0%	0%
Profit Margin	--	-627.27%	0%	0%	0%	0%
Free Cash Flow Margin	--	-645.45%	0%	0%	0%	0%
EBITDA	--	-73	-128	-107	-95	-29
EBITDA Margin	--	-663.63%	0%	0%	0%	0%
D&A For EBITDA	0	0	1	1	1	1
EBIT	--	-73	-129	-108	-96	-30
EBIT Margin	--	-663.63%	0%	0%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Bioatla Inc (BCAB) Price

BCAB Stock Price Chart

BCAB Income

Follow-Up Questions